Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antiviral drug |
| gptkbp:activeIngredient |
gptkb:bulevirtide
|
| gptkbp:alternativeName |
gptkb:bulevirtide
gptkb:Hepcludex |
| gptkbp:approvalYear |
2020
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
J05AX30
|
| gptkbp:developer |
gptkb:Hepatera
gptkb:MYR_GmbH |
| https://www.w3.org/2000/01/rdf-schema#label |
myrcludex B
|
| gptkbp:mechanismOfAction |
NTCP inhibitor
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:usedFor |
treatment of chronic hepatitis B
treatment of chronic hepatitis D |
| gptkbp:bfsParent |
gptkb:NTCP
|
| gptkbp:bfsLayer |
6
|